Relief Therapeutics

Views & Analysis

While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus. CEO Dr.

News

The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.